Rapid Micro Biosystems (RPID) Operating Income (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Operating Income of -$13.9 million for Q1 2026, down 13.44% sequentially from -$12.2 million in Q4 2025, and down 18.79% YoY from -$17.1 million in Q1 2025.
Rapid Micro Biosystems (RPID) Operating Income (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Operating Income for 7 years, with the latest figure at -$13.9 million in Q1 2026.
- Quarterly Operating Income fell 18.79% year-over-year to -$13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.6 million (down 4.81% YoY) and the FY2025 annual result came in at -$47.4 million, up 5.06% from the prior year.
- Operating Income retreated to -$13.9 million in Q1 2026 per RPID's latest filing, from -$12.2 million in the prior quarter.
- Over five years, Operating Income peaked at -$10.2 million in Q4 2024 and troughed at -$17.3 million in Q4 2022.
- A 5-year average of -$13.6 million and a median of -$13.9 million in 2026 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2023: Operating Income slumped 54.77% in 2022, then rose 29.39% in 2023.
- Over 5 years, Operating Income stood at -$17.3 million in 2022, then rose by 29.39% to -$12.2 million in 2023, then gained by 16.07% to -$10.2 million in 2024, then decreased by 19.38% to -$12.2 million in 2025, then dropped by 13.44% to -$13.9 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$13.9 million, -$12.2 million, and -$11.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Rapid Micro Biosystems | 80.98 Mn | 61.21 Mn | 1.21 Mn | -12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.32 Mn |
| Mar 31, 2026 | -13.85 Mn |
| Dec 31, 2025 | -12.21 Mn |
| Sep 30, 2025 | -11.37 Mn |
| Jun 30, 2025 | -12.15 Mn |
| Mar 31, 2025 | -11.66 Mn |
| Dec 31, 2024 | -10.23 Mn |
| Sep 30, 2024 | -12.04 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Mar 31, 2024 | -14.27 Mn |
| Dec 31, 2023 | -12.19 Mn |
| Sep 30, 2023 | -14.45 Mn |
| Jun 30, 2023 | -15.05 Mn |
| Mar 31, 2023 | -14.87 Mn |
| Dec 31, 2022 | -17.26 Mn |
| Sep 30, 2022 | -16.89 Mn |
| Jun 30, 2022 | -14.07 Mn |
| Mar 31, 2022 | -15.00 Mn |
| Dec 31, 2021 | -14.56 Mn |
| Sep 30, 2021 | -12.12 Mn |